The top eQTL for XBP1 represents a GWAS risk variant for breast cancer [69] upon TBOOH treatment (r2 = 0.802) and for ovarian cancer [70] upon TBOOH treatment (r2 = 0.73) and HC treatment (r2 = 0.746). This evidence concerns the gene XBP1 and breast carcinoma.